【Bryan】評論
Unlike sulfonylureas, Metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects (except in special circumstances, see PRECAUTIONS) and does not cause hyperinsulinemia. With Metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.
【더보이즈讓我中簽】評論
(D) Metformin-主要是抑制肝臟醣質新生作用，和抑制腸道的葡萄糖吸收，增加胰島素的敏感性，非促進其釋放